UBS Group AG - Vivoryon Therapeutics N.V. - Halle
Below you will find information from the register substantial holdings and gross short positions. The information has been provided by the organisation.
Date of transaction
04 mar 2024
Person obliged to notify
UBS Group AG
Issuing institution
Vivoryon Therapeutics N.V.
Place of residence
Halle
Distribution in numbers
| Type of share | Number of shares | Number of voting rights | Capital interest | Voting rights | Manner of disposal | Settlement |
|---|---|---|---|---|---|---|
| Type of shareGewoon aandeel | Number of shares595.656,00 | Number of voting rights595.656,00 | Capital interestReëel | Voting rightsReëel | Manner of disposalMiddellijk (UBS AG, UBS Asset Management (UK) Ltd, UBS Europe SE, UBS Fund Management (Luxembourg) S.A., Credit Suisse Fund Management S.A., Credit Suisse (Schweiz) AG) | SettlementFysieke levering |
| Type of shareGewoon aandeel | Number of shares278.116,00 | Number of voting rights278.116,00 | Capital interestPotentieel | Voting rightsPotentieel | Manner of disposalMiddellijk (UBS AG, UBS Switzerland AG) | SettlementFysieke levering |
Distribution in percentages
| Type | Total holding | Directly real | Directly potential | Indirectly real | Indirectly potential |
|---|---|---|---|---|---|
| TypeKapitaalbelang | Total holding3,35 % | Directly real0,00 % | Directly potential0,00 % | Indirectly real2,29 % | Indirectly potential1,07 % |
| TypeStemrecht | Total holding3,35 % | Directly real0,00 % | Directly potential0,00 % | Indirectly real2,29 % | Indirectly potential1,07 % |
Date last update: 25 June 2026